2012
DOI: 10.1155/2012/540127
|View full text |Cite
|
Sign up to set email alerts
|

Penicillin Susceptibility and Macrolide‐Lincosamide‐Streptogramin B Resistance in Group B Streptococcus Isolates from a Canadian Hospital

Abstract: The sampled GBS population showed no sign of reduced penicillin susceptibility, with all being well under susceptible minimum inhibitory concentration values. These data are congruent with the large body of evidence showing that penicillin G remains the most reliable clinical antibiotic for IAP. Clindamycin and erythromycin resistance was higher than expected, contributing to a growing body of evidence that suggests the re-evaluation of clindamycin and erythromycin IAP is warranted.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 15 publications
(9 reference statements)
0
3
0
Order By: Relevance
“…At present, the resistance rate of S. agalactiae to erythromycin in mastitis was as high as 94.1% from some parts of China, while India was 33.3% (Jain et al, 2012). Previous studies also found that the resistance rate of group B Streptococcus against erythromycin was also increasing by years in Canada and Taiwan (Sherman et al, 2012;Ko et al, 2001;Helena et al, 1997). The resistance rate of Streptococcus suis to macrolides was more than 50% (Martel et al, 2001), In Asia, such as China, Vietnam and Korea, clinical isolates of S. pneumoniae had resistance rates of over 70% to macrolides (Song et al, 2004;Sahm et al, 2008).…”
Section: Discussionmentioning
confidence: 92%
“…At present, the resistance rate of S. agalactiae to erythromycin in mastitis was as high as 94.1% from some parts of China, while India was 33.3% (Jain et al, 2012). Previous studies also found that the resistance rate of group B Streptococcus against erythromycin was also increasing by years in Canada and Taiwan (Sherman et al, 2012;Ko et al, 2001;Helena et al, 1997). The resistance rate of Streptococcus suis to macrolides was more than 50% (Martel et al, 2001), In Asia, such as China, Vietnam and Korea, clinical isolates of S. pneumoniae had resistance rates of over 70% to macrolides (Song et al, 2004;Sahm et al, 2008).…”
Section: Discussionmentioning
confidence: 92%
“…Erythromycin resistance was also identified in 1/3 of all GBS isolates and is no longer recommended for GBS IAP. One report from Canada in 2010-2011 found 26.6% of 158 GBS isolates resistant 38 while another study in upstate New York found resistance in 38.4% of 688 GBS isolates 39 . The bacteriostatic mechanism of antimicrobial action, incomplete placental transfer and unclear fetal/neonatal PK suggest that clindamycin may not provide the same level of protection from GBS infection as provided by beta-lactam antibiotic IAP, even with susceptible isolates.…”
Section: Clindamycinmentioning
confidence: 99%
“…Streptococcus agalactiae infections are usually treated with penicillin. Nevertheless, with the presence of many penicillin-allergic individuals, macrolides and clindamycin remain important drug alternatives in these cases, and an increase in resistance to these has been described in several countries (Sherman et al, 2012;Lambiase et al, 2012;Kimura et al, 2013;Wang et al, 2013;Frö hlicher et al, 2014).…”
Section: Introductionmentioning
confidence: 99%